SEOUL, South Korea, June 17, 2020 /PRNewswire/ -- Yuyu Pharma (CEO Robert Wonsang Yu, KRX 000220) and SD BIOSENSOR (CEO Hyo-Keun, Lee) entered into a Supply Agreement, where Yuyu Pharma will export ...
WASHINGTON — An at-home COVID-19 testing kit is being recalled for failing to meet FDA requirements. The lack of FDA approval means that there is not sufficient data demonstrating that the test's ...
The number of new COVID-19 cases is breaking records day after day. To respond to the spread of the Omicron variant, the government has shifted the COVID-19 diagnostic testing system to focus on ...
SD Biosensor, a Korean developer of COVID-19 test kits, said Friday it has signed a deal to buy an Italian medical device distributor for 61.9 billion won ($49.8 million) in an effort to tap deeper ...
The Federal Government has approved two Rapid Diagnostic Test (RDTs) kits manufactured by SD Biosensor and Abbott for covid-19 testing. It explained that while RDTs provide a faster turnaround time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results